Legato Capital Management LLC bought a new stake in Chemed Corporation (NYSE:CHE – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 1,615 shares of the company’s stock, valued at approximately $691,000.
Several other hedge funds have also recently made changes to their positions in CHE. Geneos Wealth Management Inc. increased its position in shares of Chemed by 330.4% in the 1st quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock valued at $61,000 after acquiring an additional 76 shares during the period. Arrowstreet Capital Limited Partnership boosted its holdings in shares of Chemed by 67.0% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 11,365 shares of the company’s stock valued at $5,534,000 after acquiring an additional 4,560 shares during the last quarter. Marshall Wace LLP acquired a new stake in shares of Chemed in the second quarter worth $579,000. Brown Advisory Inc. increased its stake in shares of Chemed by 36.9% in the second quarter. Brown Advisory Inc. now owns 549 shares of the company’s stock worth $267,000 after acquiring an additional 148 shares during the period. Finally, Cerity Partners LLC increased its stake in shares of Chemed by 237.7% in the second quarter. Cerity Partners LLC now owns 4,451 shares of the company’s stock worth $2,165,000 after acquiring an additional 3,133 shares during the period. 95.85% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of research analysts recently issued reports on the stock. Zacks Research upgraded shares of Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Weiss Ratings raised Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, April 29th. Oppenheimer reduced their price objective on Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a research note on Friday, February 27th. Wall Street Zen downgraded Chemed from a “buy” rating to a “hold” rating in a research note on Saturday. Finally, Royal Bank Of Canada raised their target price on Chemed from $422.00 to $436.00 and gave the stock a “sector perform” rating in a report on Monday, April 27th. Two equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $501.50.
Insider Buying and Selling at Chemed
In related news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction dated Friday, May 1st. The stock was sold at an average price of $421.13, for a total value of $842,260.00. Following the completion of the transaction, the chief executive officer owned 90,219 shares in the company, valued at $37,993,927.47. The trade was a 2.17% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 3.33% of the stock is currently owned by corporate insiders.
Chemed Stock Performance
CHE opened at $438.11 on Wednesday. The firm has a fifty day moving average price of $401.79 and a 200 day moving average price of $424.94. Chemed Corporation has a 1 year low of $365.20 and a 1 year high of $581.20. The stock has a market cap of $5.81 billion, a P/E ratio of 23.88, a P/E/G ratio of 1.65 and a beta of 0.54. The company has a debt-to-equity ratio of 0.11, a current ratio of 0.85 and a quick ratio of 0.83.
Chemed (NYSE:CHE – Get Free Report) last released its quarterly earnings results on Thursday, April 23rd. The company reported $5.65 EPS for the quarter, beating the consensus estimate of $5.30 by $0.35. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The company had revenue of $657.51 million for the quarter, compared to analyst estimates of $659.22 million. During the same quarter last year, the business earned $5.63 earnings per share. The firm’s revenue was up 1.6% on a year-over-year basis. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. Equities research analysts anticipate that Chemed Corporation will post 22.3 earnings per share for the current year.
Chemed Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 16th. Investors of record on Thursday, May 28th will be paid a $0.60 dividend. This represents a $2.40 annualized dividend and a dividend yield of 0.5%. The ex-dividend date is Thursday, May 28th. Chemed’s payout ratio is currently 13.08%.
Chemed Company Profile
Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.
The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.
Featured Stories
- Five stocks we like better than Chemed
- Banks Are Buying Back Stock Hand Over Fist, Including These 3 Names
- 2 Aluminum Stocks Poised for Big Tariff-Related Gains
- AutoZone’s Pullback Sets Up a Long-Term Buying Opportunity
- AST SpaceMobile’s June Launch Plan Puts Its 2026 Satellite Goal Back in Focus
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHE – Free Report).
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.
